This session is now available online. Click here to watch.

Mini-med to explain the promise
of adult, embryonic stem cell research

Stem cells are, quite simply, remarkable. They’re the human body’s built-in repair system and can theoretically divide without limit in order to replenish or repair other cells that have died or been damaged.

But not all stem cells are equal. Researchers believe that embryonic stem cells can do much more than adult stem cells.

When an embryonic stem cell divides, each new cell has the amazing potential of becoming any other kind of cell in the body . . . a brain cell, muscle cell or islet cell. That’s why this area of science is so promising, because it could revolutionize how we treat a myriad of diseases, conditions and disabilities. These include emphysema, Parkinson’s, spinal cord injuries, stroke, burns, heart disease, diabetes, liver and kidney disease, osteoarthritis and rheumatoid arthritis.

Scientists have worked with adult stem cells for the past 40 years. Blood stem cells are routinely used for bone
marrow transplants to successfully treat such cancers as leukemia and lymphoma. However, scientists have been working with human embryonic stem cells for only eight years. First isolated in 1998, researchers now believe that they hold enormous potential for cell-based regenerative therapies.

While the promise is high, the facts about the potential and limitations of embryonic and adult stem cell research are oftentimes confused or distorted. Come to Mini-Medical School and learn why this science is so exciting. UNMC’s experts in stem cell research will outline the history behind the research and explain the difference between embryonic and adult stem cells, their function and potential. Panelists will answer your questions and help you sort hype from hope.

Tuesday, November 28, 2006
6:30-9 p.m. CST
5:30-8 p.m. MST